Morgan Stanley analyst Tejas Savant maintained a Hold rating on Cue Health (HLTH – Research Report) today and set a price target of $8.00. The company’s shares closed yesterday at $2.01.
According to TipRanks, Savant is an analyst with an average return of -9.0% and a 34.34% success rate. Savant covers the Healthcare sector, focusing on stocks such as Seer, Hologic, and Illumina.
Currently, the analyst consensus on Cue Health is a Hold with an average price target of $8.00.
See the top stocks recommended by analysts >>
HLTH market cap is currently $301.9M and has a P/E ratio of -2.16.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Cue Health Inc is a health technology company. It puts consumers in control of health information and places diagnostic information at the center of care. It enables people to manage health through real-time, actionable and connected health data. Further, it offers individuals, enterprises, government agencies and healthcare providers access to lab-quality diagnostic testing at home, at work, or at the point-of-care, all in a device that fits in the palm of hand.
Read More on HLTH:
